104 results
424B5
ARAV
Aravive Inc
28 Jun 23
Prospectus supplement for primary offering
6:01am
for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted … defeasance;
additions to or changes in the provisions relating to satisfaction and discharge of the indenture;
additions to or changes in the provisions
8-K
EX-10.1
jp3qefe3
11 Apr 23
Aravive Appoints Carolina Petrini as Chief Commercial Officer
7:10am
8-K/A
EX-10.1
js78sr4
28 Oct 22
Other Events
4:05pm
8-K
lqdzaxw7e 37nh
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-99.1
7fkvv6i
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-4.3
azh8fjqvotorhe3
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-4.2
os8vw
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-4.1
9rmuwdyc
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.1
f9rvy
26 Oct 22
Aravive Announces Approximately $41.5 Million Private Placement Financing
4:35pm
8-K
EX-10.1
c0vt l26i4746ql
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
8-K
EX-10.1
yswj 9mzwriv
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-4.2
v2vwss5mtqrmnp33y
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am
8-K
EX-4.1
lh5ye6tnkyz
31 Mar 22
Aravive Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:26am